Assessment of immune response against peptides with motifs using peptide ELISA.

<p>Immunoreactivity against the 12 selected peptides was determined in a set of 21 <i>O</i>. <i>volvulus</i> infected individuals (group 1), healthy controls from Southern Africa (group 2), healthy controls from Belgium (group 3) and individuals infected with HIV (group 4), HCV (group 5), Dengue (group 6), <i>P</i>. <i>falciparum</i> (group 7) and <i>W</i>. <i>bancrofti</i> (group 8) and asthma patients (group 9).